Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent has acquired from Erytech Pharma its state-of-the-art, commercial-scale cell therapy manufacturing facility in Princeton, New Jersey, for $44.5 million.
read more
Continuum Clinical and Skipta announced the launch of the Center for Observational Research, connecting physicians and available research opportunities within a private and secure digital environment.
read more
Enyo Pharma has decided to open its first wholly owned subsidiary in Melbourne, Australia, because of its clinical trials development capabilities and conditions offered by the government.
read more
Lonza is opening a dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies.
read more
Cardinal Health announced it has been awarded a $750,000 contract by the FDA to implement an 18-month real world evidence (RWE) study as part of the agency's efforts to advance the applicability of RWE in regulatory decision-making.
read more
Adare Pharma Solutions announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging capabilities.
read more
Eurofins Scientific has signed an agreement to acquire DiscoverX.
read more
Thermo Fisher has signed agreements with Daiichi Sankyo and Takeda designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs.
read more
The EC has licensed Dupixent® for use in adults and adolescents 12 years and older as an add-on maintenance treatment for severe asthma with type 2 inflammation.
read more
Wednesday, April 08, 2020
The U.S. Food and Drug Administration (FDA) has released the following statement regarding the current compounding policy.
read more
Leading specialist development pharma, Amzell B.V, has signed a license and development agreement with Amring Pharmaceuticals Inc., a subsidiary of SEVER Life Sciences B.V., for the commercial rights to one of its leading clinical-stage candidates.
read more
Veristat, a full service Clinical Research Organization (CRO), is expanding its clinical research offerings into Europe through the acquisition of UK-based CRO, Spero Oncology. Spero Oncology is a UK-based CRO specializing in providing clinical ...
read more
Wednesday, August 10, 2016
Agilent Technologies Inc. has acquired 20 acres in Weld County, Colorado, on which it plans to build a pharmaceutical manufacturing facility.
The expansion will enable the company to more than double its commercial manufacturing capacity for nucleic...
read more
Wednesday, February 09, 2022
Berkshire Sterile Manufacturing (BSM) has added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions.
read more
Medidata, a Dassault Systèmes company, announced that Labcorp has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of...
read more